The WACC of Arecor Therapeutics PLC (AREC.L) is 12.6%.
| Range | Selected | |
| Cost of equity | 11.30% - 14.10% | 12.70% |
| Tax rate | 11.80% - 14.80% | 13.30% |
| Cost of debt | 7.00% - 7.50% | 7.25% |
| WACC | 11.2% - 14.0% | 12.6% |
| Category | Low | High |
| Long-term bond rate | 4.0% | 4.5% |
| Equity market risk premium | 6.0% | 7.0% |
| Adjusted beta | 1.22 | 1.31 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 11.30% | 14.10% |
| Tax rate | 11.80% | 14.80% |
| Debt/Equity ratio | 0.01 | 0.01 |
| Cost of debt | 7.00% | 7.50% |
| After-tax WACC | 11.2% | 14.0% |
| Selected WACC | 12.6% | |